Home Proteon Therapeutics

Proteon Therapeutics

In operation
Post-IPO Round
Drug Developer
Basic
Enterprise Profile

Basic Information

Proteon Therapeutics, Inc. is a biopharmaceutical company developing drugs to meet the medical needs of patients with kidney and vascular diseases. Our first product, BAFASAL®, is a feed additive that prevents and eliminates salmonella in poultry farms.
Proteon Therapeutics, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2001
info@proteontx.com

Enterprise Profile

Industrial Sector
New Drug Development Feed Biological Drug Production
Concept
Cardiovascular Disease Urinary System Diseases
Application Scenarios
Biologics Innovative Drugs